These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 549717)

  • 21. Altered bioavailability of drugs in the eye due to drug-protein interaction.
    Mikkelson TJ; Chrai SS; Robinson JR
    J Pharm Sci; 1973 Oct; 62(10):1648-53. PubMed ID: 4752109
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y; Chen Z; Song J
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Formulations containing complexes of ophthalmic drugs with tannic acid: "in vitro" and "in vivo" evaluation].
    Monti D; Chetoni P; Morini ML; Saettone MF
    Boll Chim Farm; 1996 Feb; 135(2):136-8. PubMed ID: 9044562
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of instilled drugs in the human eye.
    Nagataki S; Mishima S
    Int Ophthalmol Clin; 1980; 20(3):33-49. PubMed ID: 6998899
    [No Abstract]   [Full Text] [Related]  

  • 25. Corneal metabolism of pilocarpine in pigmented rabbits.
    Lee VH; Hui HW; Robinson JR
    Invest Ophthalmol Vis Sci; 1980 Feb; 19(2):210-3. PubMed ID: 7351355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypotensive and miotic action of stabilized solutions of physostigmine and physostigmine-pilocarpine (experimental data)].
    Fauziia Saied AKh; Sporova NA; Kondrat'eva TS
    Vestn Oftalmol; 1978; (5):17-8. PubMed ID: 706040
    [No Abstract]   [Full Text] [Related]  

  • 27. [Autoradiographic studies on uptake of ophthalmic agents instilled into the conjunctival cul-de-sac].
    Mizukawa T; Sakuma M; Sato Y
    Nihon Ganka Kiyo; 1966 Nov; 17(11):1047-58. PubMed ID: 6009697
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of topical antiglaucoma eye drops on prostaglandin E(2)-induced aqueous flare elevation in pigmented rabbits.
    Hayasaka Y; Hayasaka S; Zhang XY; Nagaki Y
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1142-5. PubMed ID: 11923258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E 1 and aqueous humor dynamics.
    Kass MA; Podos SM; Moses RA; Becker B
    Invest Ophthalmol; 1972 Dec; 11(12):1022-7. PubMed ID: 4638977
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of the antiglaucomatous activity of Glauplex 2 and pilocarpine nitrate on alpha-chymotrypsin-induced experimental glaucoma].
    Andermann G; de Burlet G; Cannet C
    J Fr Ophtalmol; 1982; 5(8-9):499-504. PubMed ID: 6897256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic hydrolysis of pilocarpine.
    Ellis PP; Littlejohn K; Deitrich RA
    Invest Ophthalmol; 1972 Sep; 11(9):747-51. PubMed ID: 5053449
    [No Abstract]   [Full Text] [Related]  

  • 32. In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine.
    Lin HR; Sung KC; Vong WJ
    Biomacromolecules; 2004; 5(6):2358-65. PubMed ID: 15530052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles as drug carriers in ophthalmology.
    Harmia T; Speiser P; Kreuter J
    Pharm Acta Helv; 1987; 62(12):322-31. PubMed ID: 3441476
    [No Abstract]   [Full Text] [Related]  

  • 34. Stability of pilocarpine hydrochloride and pilocarpine nitrate ophthalmic solutions submitted by U.S. hospitals.
    Kreienbaum MA; Page DP
    Am J Hosp Pharm; 1986 Jan; 43(1):109-17. PubMed ID: 3953580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The bioavailability of eye drops].
    Andermann G; Andermann C; Mergel D
    Pharm Acta Helv; 1978; 53(9-10):291-300. PubMed ID: 740715
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of the dropsize on the elimination of an ophthalmic solution from the precorneal area of human eyes.
    Ludwig A; Van Ooteghem M
    Pharm Acta Helv; 1987; 62(2):56-60. PubMed ID: 3575342
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contribtuion to the study of the stability of pilocarpine in aqueous medium. 3. Stability of ophthalmic solutions].
    Baeschlin K; Etter JC
    Pharm Acta Helv; 1969 Jun; 44(6):348-55. PubMed ID: 5805009
    [No Abstract]   [Full Text] [Related]  

  • 38. Ocular penetration of pilocarpine: the effect on concentration on the ocular penetration of pilocarpine.
    Ramer RM; Gasset AR
    Ann Ophthalmol; 1974 Nov; 6(11):1160-2. PubMed ID: 4429321
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies of releasing rate of pilocarpine hydrochloride from hydrogel eye ointments].
    Kecik T; Szlaski J; Portacha L; Lewandowski P; Marchlewska B; Pacak I
    Klin Oczna; 1993 Jul; 95(7):263-4. PubMed ID: 8121144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.